Academy Panel Urges Companies To Help Train Young Bioscientists

Report says biotech firms must pick up the slack to supplement federal funding of the next generation of scientists WASHINGTON -- Biotechnology companies are running out of scientists, and it may be up to industry itself to educate the next generation of biochemists, according to a new report from the National Research Council. The report, funded by the National Institutes of Health at the behest of Congress, recommends that federally supported traineeships and fellowships for biomedical grad

Written byDiana Morgan
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share


Report says biotech firms must pick up the slack to supplement federal funding of the next generation of scientists
WASHINGTON -- Biotechnology companies are running out of scientists, and it may be up to industry itself to educate the next generation of biochemists, according to a new report from the National Research Council.

The report, funded by the National Institutes of Health at the behest of Congress, recommends that federally supported traineeships and fellowships for biomedical graduate students be increased from the current level of 3,681 positions to 5,200 by 1993.

With the number of biotechnology firms having grown dramatically since the early 1980s, most of them can't find qualified scientists in areas such as pharmacology, toxicology, and enzymology, notes the Committee on Biomedical and Behavioral Research Personnel of the National Academy of Sciences. In particular, the panel recommends a 41% increase - from $91.5 million in 1987 to $129.2 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies